# Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)

> **NCT05263557** · NA · UNKNOWN · sponsor: **Royal College of Surgeons, Ireland** · enrollment: 20 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome
- Insulin Resistance
- Androgen; Hypersecretion
- Endocrine System Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Dehydroepiandrosterone (DHEA)
- **DIETARY_SUPPLEMENT:** 11-ketoandrostenedione (11KA4)

## Key facts

- **NCT ID:** NCT05263557
- **Lead sponsor:** Royal College of Surgeons, Ireland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-19
- **Primary completion:** 2024-12
- **Final completion:** 2024-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2023-07-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05263557

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05263557, "Dissecting the IMpact of 11-OXygenated and Classic Androgens on Skeletal Muscle Insulin Sensitivity (DIMOXIS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05263557. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*